Efficacy of gemcitabine as second-line therapy after S-1 therapy failure in advanced pancreatic carcinoma

被引：2
|
作者：
Fukahori, Masaru [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF GEMCITABINE AS SECOND-LINE THERAPY AFTER FAILURE OF S-1 THERAPY FOR METASTATIC PANCREATIC CARCINOMA
    Fukahori, M.
    Kondo, S.
    Ueno, H.
    Shimizu, S.
    Mitsunaga, S.
    Ikeda, M.
    Yamaguchi, T.
    Sakamoto, Y.
    Morizane, C.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 123 - 123
  • [2] S-1 Monotherapy as Second-line Treatment for Advanced Pancreatic Cancer after Gemcitabine Failure
    Todaka, Akiko
    Fukutomi, Akira
    Boku, Narikazu
    Onozawa, Yusuke
    Hironaka, Shuichi
    Yasui, Hirofumi
    Yamazaki, Kentaro
    Taku, Keisei
    Machida, Nozomu
    Sakamoto, Takeshi
    Tomita, Hideharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (06) : 567 - 572
  • [3] SECOND-LINE THERAPY OF S-1 FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCER AFTER FAILURE TO CISPLATIN PLUS GEMCITABINE
    Kobayashi, S.
    Ueno, M.
    Ohkawa, S.
    Gouda, Y.
    Irie, K.
    Morimoto, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 43 - 43
  • [4] Efficacy of S-1 in second-line chemotherapy after nab-paclitaxel plus gemcitabine for patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Kato, Ryo
    Ueda, Masami
    Tsuda, Yujiro
    Nakashima, Shinsuke
    Ohta, Katsuya
    Matsuyama, Jin
    Ikenaga, Masakazu
    Tominaga, Shusei
    CANCER REPORTS, 2020, 3 (02)
  • [5] Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
    Fumet, Jean-David
    Vincent, Julie
    Bengrine, Leila
    Hennequin, Audrey
    Granconato, Laura
    Palmier, Remi
    Ghiringhelli, Francois
    ANTICANCER RESEARCH, 2020, 40 (07) : 4011 - 4015
  • [6] SECOND-LINE CHEMOTHERAPY WITH S-1 AFTER CISPLATIN AND GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Ueda, Shinya
    Kawakami, Hisato
    Okamoto, Wataru
    Nishina, Shinichi
    Kudo, Toshihiro
    Makimura, Chihiro
    Kiyota, Hidemi
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Fujisaka, Yasuhito
    Miyazaki, Masaki
    Turutani, Junji
    Okamoto, Isamu
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [7] Neutropenia as a prognostic factor and safety of second-line therapy with S-1 for advanced or recurrent pancreatic cancer
    Ikagawa, Makiko
    Kimura, Michio
    Iwai, Mina
    Usami, Eiseki
    Yoshimura, Tomoaki
    Yasuda, Kimio
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (03) : 283 - 288
  • [8] Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
    Qiu, Zhi-Yuan
    Qin, Rong
    Tian, Guang-Yu
    Zhang, Zhao
    Chen, Meifang
    He, Han
    Xi, Yan
    Wang, Yan
    MEDICINE, 2021, 100 (17) : E25630
  • [9] Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer
    Romain Altwegg
    Marc Ychou
    Vanessa Guillaumon
    Simon Thezenas
    Pierre Senesse
    Nicolas Flori
    Thibault Mazard
    Ludovic Caillo
    Stéphanie Faure
    Emmanuelle Samalin
    Eric Assenat
    World Journal of Gastroenterology, 2012, (12) : 1357 - 1364
  • [10] Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1178 - 1179
12345